Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Langya virus/LayV N/Nucleocapsid protein Protein, N-His (YVV18001)

Applications:ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system:E. coli
Accession:UUV47202.1
Protein length:Met1-Ser539
Overview

Catalog No.

YVV18001

Expression system

E. coli

Species

Langya virus

Protein length

Met1-Ser539

Predicted molecular weight

62.64 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

UUV47202.1

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Nucleoprotein, N, Nucleocapsid protein, NC, Protein N, N Protein

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Langya virus/LayV N/Nucleocapsid protein
References

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. PMID: 32292689

The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients. PMID: 33515911

SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases. PMID: 35434592

Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. PMID: 33520309

Structures of the N- and C-terminal domains of MHV-A59 nucleocapsid protein corroborate a conserved RNA-protein binding mechanism in coronavirus. PMID: 21203940

Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein. PMID: 32703419

Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view. PMID: 33897053

Potential compound from herbal food of Rhizoma Polygonati for treatment of COVID-19 analyzed by network pharmacology: Viral and cancer signaling mechanisms. PMID: 32837538

Prospects of NIR fluorescent nanosensors for green detection of SARS-CoV-2. PMID: 35370362

Nucleocapsid (N) Gene Mutations of SARS-CoV-2 Can Affect Real-Time RT-PCR Diagnostic and Impact False-Negative Results. PMID: 34960743

Interaction between molecules of hantavirus nucleocapsid protein. PMID: 11457990

Tracking the COVID-19 vaccines: The global landscape. PMID: 36995773

Mutational insights into the envelope protein of SARS-CoV-2. PMID: 33319124

Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses. PMID: 32765822

Analytical performance of the point-of-care BIOSYNEX COVID-19 Ag BSS for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: a prospective field evaluation during the COVID-19 third wave in France. PMID: 34689310

A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis. PMID: 36059866

Interplay between interferon-mediated innate immunity and porcine reproductive and respiratory syndrome virus. PMID: 22590680

Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France. PMID: 33746093

Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses. PMID: 36158162

Structure of the paramyxovirus parainfluenza virus 5 nucleoprotein-RNA complex. PMID: 25831513

Evaluation of the Practicability of Biosynex Antigen Self-Test COVID-19 AG+ for the Detection of SARS-CoV-2 Nucleocapsid Protein from Self-Collected Nasal Mid-Turbinate Secretions in the General Public in France. PMID: 34943454

Variants of SARS-CoV-2: Influences on the Vaccines' Effectiveness and Possible Strategies to Overcome Their Consequences. PMID: 36984508

Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases. PMID: 34883243

Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions. PMID: 34924802

Establishment of a quantitative RT-PCR detection of SARS-CoV-2 virus. PMID: 34920757

Identification of an amino acid change that affects N protein function in vesicular stomatitis virus. PMID: 7996152

First Report of Citrus leprosis virus Nuclear Type in Sweet Orange in Colombia. PMID: 30708809

Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples. PMID: 33879983

Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins. PMID: 33778182

Longitudinal study comparing IgG antibodies induced by heterologous prime-boost COVID-19 vaccine. PMID: 36478244

Interactions among SARS-CoV accessory proteins revealed by bimolecular fluorescence complementation assay. PMID: 26579480

Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation. PMID: 33869895

SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses. PMID: 34170314

Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics. PMID: 35128175

In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysis. PMID: 34334813

Envelope protein palmitoylations are crucial for murine coronavirus assembly. PMID: 18184706

Commercialized kits to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in health care workers. PMID: 35999826

Colorimetric and fluorometric reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for diagnosis of SARS-CoV-2. PMID: 36089609

Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh. PMID: 34251592

Longitudinal evaluation of the Abbott ARCHITECT SARS-CoV-2 IgM and IgG assays in a pediatric population. PMID: 33623814

Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop. PMID: 32505910

Association of matrix protein of respiratory syncytial virus with the host cell membrane of infected cells. PMID: 14689285

Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: Analysis of 944 patients in Apulia, Italy. PMID: 33545362

Relationship between within-host fitness and virulence in the vesicular stomatitis virus: correlation with partial decoupling. PMID: 22951843

Reverse genetics for peste-des-petits-ruminants virus (PPRV): promoter and protein specificities. PMID: 17350130

Viruses in the Anopheles A, Anopheles B, and Tete serogroups in the Orthobunyavirus genus (family Bunyaviridae) do not encode an NSs protein. PMID: 19439468

Inhibition of the antiviral action of interferon by tick salivary gland extract. PMID: 10760186

Efficacy of the neutralizing antibodies after the booster dose on SARS-CoV-2 Omicron variant and a two-year longitudinal antibody study on Wild Type convalescents. PMID: 37044040

A genome sequence of novel SARS-CoV isolates: the genotype, GD-Ins29, leads to a hypothesis of viral transmission in South China. PMID: 15626340

Genetic diversity characterization of porcine reproductive and respiratory syndrome virus isolates in Romania, based on phylogenetic analysis. PMID: 23109899

Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles. PMID: 3027375

Expression of measles virus RNA in peripheral blood mononuclear cells of patients with measles, SSPE, and autoimmune diseases. PMID: 2024495

Proteomic analysis of SARS associated coronavirus using two-dimensional liquid chromatography mass spectrometry and one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by mass spectroemtric analysis. PMID: 15253436

Analysis of polypeptides in Tacaribe virus-infected cells. PMID: 6310867

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients. PMID: 33892006

SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects. PMID: 34329696

Mapping of B-cell epitopes on the N- terminal and C-terminal segment of nucleocapsid protein from Crimean-Congo hemorrhagic fever virus. PMID: 30235312

[Expressing of N gene encoding nucleocapsid protein of vesicular stomatitis virus and elementary application in ELISA]. PMID: 16108504

Structural Basis of Human Parainfluenza Virus 3 Unassembled Nucleoprotein in Complex with Its Viral Chaperone. PMID: 34730394

Discovery of novel chromone derivatives containing a sulfonamide moiety as potential anti-TSWV agents. PMID: 34737160

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients. PMID: 35283215

Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort. PMID: 35185909

Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis. PMID: 12970438

[Preparation of specific monoclonal antibody against nucleocapsid protein of SARS coronavirus]. PMID: 15629083

Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score. PMID: 33910993

Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. PMID: 14676007

Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2. PMID: 35602487

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Langya virus/LayV N/Nucleocapsid protein Protein, N-His [YVV18001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only